Search | IOVS | ARVO Journals

Showing 1 – 20 of 141

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina March 2025

Topical Administration of Novel FKBP12 Ligand MP-004 Improves Retinal Function and Structure in Retinitis Pigmentosa Models

PDF

Araceli Lara-López; Klaudia Gonzalez-Imaz; María Rodríguez-Hidalgo; Miren Sarasola-Gastesi; Leire Escudero-Arrarás; Santiago Milla-Navarro; Pedro de la Villa; Maialen Sagartzazu-Aizpurua; José Ignacio Miranda; Jesús María Aizpurua; Adolfo López de Munain; Ainara Vallejo-Illarramendi; Javier Ruiz-Ederra
TAGS: calcium, ligands, mice, photoreceptors, retinitis pigmentosa, tacrolimus binding protein 1a, administration, topical, retina, oxidative stress, electroretinography
Invest. Ophthalmol. Vis. Sci.. 2025; 66(3):56. https://doi.org/10.1167/iovs.66.3.56

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Bioanalytical solutions and immunogenicity challenges of species-matched antibodies in preclinical studies while investigating protein-loaded long-acting intravitreal delivery technologies

Kelly Loyet; Hilda Hernandez-Barry; Kathy Barrett; Mauricio Maia; Yanqiu Liu; Hanine Rafidi; Danielle Mandikian; Andy Boswell; Joyce Chan; Laetitia Comps-Agrar; Susan Ritger Crowell; Steven Laing; Amin Famili; Whitney Shatz-Binder; Devin Tesar; Robert Kelley

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3785.

ARVO Imaging in the Eye Conference Abstract June 2023

Central Serous Chorioretinopathy with Bacillary Layer Detachment

Antonio MARCELO BARBANTE Casella; Raphaela M Fuganti; Luiz Lima; Ahmad Mansour; Michel Farah; Mauricio Maia; Luis Roisman; Francisco Rodriguez; Juliana Prazeres; Jose Ignacio Fernández-Vigo; Suthasinee Sinawat; Jay Chhablani; Lorenzo López-Guajard; Igor Kozak; A Osman Saatci; Stephen Schwartz

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0044.

ARVO Annual Meeting Abstract June 2023

Development of IL-33/ST2 pathway activity biomarkers and their evaluation in patients with geographic atrophy secondary to AMD

Vahan Indjeian; Hsu-Hsin Chen; Luz Orozco; Ainhoa Echeverria; Trung Nguy; Ling Ma; Randall Dere; Mauricio Maia; Jennifer Hoffman; Simon S. Gao; Cheryl Schofield

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2718.

ARVO Annual Meeting Abstract June 2023

MP-004, a novel FKBP12 ligand as a candidate for treating IRDs

Araceli Lara-López; Klaudia González-Imaz; Maria Rodriguez-Hidalgo; José Ignacio Miranda; Maialen Sagartzazu-Aizpurua; Jesus María Aizpurua; Ainara Vallejo-Illarramendi; Javier Ruiz-Ederra

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2595.

ARVO Annual Meeting Abstract June 2022

Aqueous humor vascular endothelial growth factor pharmacodynamics in the phase 3 Archway trial of the Port Delivery System with ranibizumab

Murtaza Adam; Laura Barras; Mauricio Maia; Shamika Gune; Katie Maass; Michael Chang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4285.

ARVO Annual Meeting Abstract June 2022

Secondary surgery after failed macular hole repair in a real-world setting – results from an international, multicenter, retrospective study

Etienne Schonbach; Darren Knight; Chris Wu; J Fernando Arevalo; Luiza Bittencourt de Souza; Jay Chhablani; Kátia Delalibera Pacheco; Nikolaus Feucht; Prashanth Iyer; Igor Kozak; André Maia; Mathias Maier; Marina Roizenblatt; William Smiddy; Warren Sobol; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3396 – F0296.

ARVO Annual Meeting Abstract June 2021

Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial

Peter A Campochiaro; Shamika Gune; Mauricio Maia; Han Ting Ding; Katie Maass

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):350.

ARVO Annual Meeting Abstract June 2021

Immunogenicity profile of the Port Delivery System with ranibizumab in patients with nAMD

Margaret Chang; Katie Maass; Galin Jackson Spicer; Natasha Singh; Steven Blotner; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):227.

ARVO Annual Meeting Abstract June 2021

Comparison of the quality of life between glaucoma and age-related macular degeneration patients living in a middle-income country.

Renato Maia Maccione; Kenzo S Tomishige; Caroline Schiave Germano; Patrícia Asperti Ottaiano; Niro Kasahara

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3599.

ARVO Annual Meeting Abstract June 2021

Comparison of self-confidence between glaucoma and age-related macular degeneration patients who live in a developing country.

Patrícia Asperti Ottaiano; Caroline Schiave Germano; Kenzo S Tomishige; Renato Maia Maccione; Niro Kasahara

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3596.

ARVO Annual Meeting Abstract June 2021

Comparison of the illness perception between age-related macular degeneration and glaucoma patients living in a middle-income country

Caroline Schiave Germano; Patrícia Asperti Ottaiano; Renato Maia Maccione; Kenzo S Tomishige; Niro Kasahara

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):307.

ARVO Annual Meeting Abstract June 2021

Comparison of depressive symptoms between age-related macular degeneration and glaucoma patients who live in a developing country.

Kenzo S Tomishige; Caroline Schiave Germano; Patrícia Asperti Ottaiano; Renato Maia Maccione; Niro Kasahara

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):296.

ARVO Annual Meeting Abstract June 2020

Pharmacokinetic (PK) Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial

Peter A Campochiaro; Shamika Gune; Mauricio Maia; Katie Maass

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1157.

ARVO Annual Meeting Abstract June 2020

Effect of weight-adjusted coffeine and propranolol, alone and combined, on simulated surgical skills

Marina Roizenblatt; Vitor Dias Gomes; Alex Treiger Grupenmacher; Felipe Muralha; Muller Gonçalves Urias; Jean Faber; Kim Jiramongkolchai; Peter L Gehlbach; Michel Eid Farah; Rubens Belfort Jr.; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3701.

ARVO Annual Meeting Abstract June 2020

Nonclinical toxicology and biocompatibility program supporting clinical development and registration of the Port Delivery System with ranibizumab

Vladimir Bantseev; Joshua Horvath; Giulio Barteselli; Shrirang Ranade; Maia Mauricio; Daniela Bumbaca; Chris Schuetz; Amy Shelton; Helen Booler

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2966.

ARVO Annual Meeting Abstract June 2020

OCT findings in Patients with Parkinson’s Disease with or Without Pramipexole Treatment

Mario L R Monteiro; Luiz Guilherme Marchesi Mello; Leandro Bortolon Bissoli; Raphael de Paula Doyle Maia; Fabio Petersen Saraiva

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5107.

ARVO Annual Meeting Abstract July 2019

Safety and retinal toxicity of a biodegradable scaffold for stem cells derived RPE implantation.Preclinical study in rabbits.

Mariana Kawamuro; rodrigo antonio brant fernandes; mauricio maia; Fernando Lojudice

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2879.

Letters to the Editor August 2018

Comments on Assays Used to Measure VEGF in the Presence of Anti-VEGF Therapeutics

PDF

Eric Wakshull; Robert Avery; Mauricio Maia
TAGS: anti-vascular endothelial growth factor therapy, therapeutics, vascular endothelial growth factor a
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4106. https://doi.org/10.1167/iovs.18-24792

ARVO Annual Meeting Abstract July 2018

Intravitreal Dexamethasone Implant Migration into the Anterior Chamber: A Multicenter Study from the Pan-American Collaborative Retina Study Group

Mariana Batista Gonçalves; Bruno Queiroz Alves; Raphael Moura; Octaviano Magalhães Júnior; André Maia; Rubens Belfort Jr; Marcos Ávila; Marcelo Zas; Mario J Saravia; Marcia Lousas; Lihteh Wu; J Fernando Arevalo; Katia Delalibera Pacheco; Michel Eid Farah; Francisco J Rodriguez; Mauricio Maia

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):390.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Topical Administration of Novel FKBP12 Ligand MP-004 Improves Retinal Function and Structure in Retinitis Pigmentosa Models

Bioanalytical solutions and immunogenicity challenges of species-matched antibodies in preclinical studies while investigating protein-loaded long-acting intravitreal delivery technologies

Central Serous Chorioretinopathy with Bacillary Layer Detachment

Development of IL-33/ST2 pathway activity biomarkers and their evaluation in patients with geographic atrophy secondary to AMD

MP-004, a novel FKBP12 ligand as a candidate for treating IRDs

Aqueous humor vascular endothelial growth factor pharmacodynamics in the phase 3 Archway trial of the Port Delivery System with ranibizumab

Secondary surgery after failed macular hole repair in a real-world setting – results from an international, multicenter, retrospective study

Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial

Immunogenicity profile of the Port Delivery System with ranibizumab in patients with nAMD

Comparison of the quality of life between glaucoma and age-related macular degeneration patients living in a middle-income country.

Comparison of self-confidence between glaucoma and age-related macular degeneration patients who live in a developing country.

Comparison of the illness perception between age-related macular degeneration and glaucoma patients living in a middle-income country

Comparison of depressive symptoms between age-related macular degeneration and glaucoma patients who live in a developing country.

Pharmacokinetic (PK) Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial

Effect of weight-adjusted coffeine and propranolol, alone and combined, on simulated surgical skills

Nonclinical toxicology and biocompatibility program supporting clinical development and registration of the Port Delivery System with ranibizumab

OCT findings in Patients with Parkinson’s Disease with or Without Pramipexole Treatment

Safety and retinal toxicity of a biodegradable scaffold for stem cells derived RPE implantation.Preclinical study in rabbits.

Comments on Assays Used to Measure VEGF in the Presence of Anti-VEGF Therapeutics

Intravitreal Dexamethasone Implant Migration into the Anterior Chamber: A Multicenter Study from the Pan-American Collaborative Retina Study Group

To View More...

You must be signed into an individual account to use this feature.